The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...
Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and ...
Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...
Researchers at Harvard Medical School developed a tool that could use artificial intelligence to accelerate drug discovery ...
A drug for pulmonary fibrosis created using artificial intelligence (AI) is showing early promise in patients.
Scientists have achieved a groundbreaking advancement in preclinical testing by growing mini human livers, known as organoids ...
The current pharmaceutical landscape demands a change in mindset. Success requires balancing speed, cost and quality while ...
Scientists at La Trobe University have discovered a previously unknown way viruses could spread around the body, potentially ...
In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...
FDA consumer safety officer discussed the challenges of navigating policy and politics in rare diseases at a recent meeting.